Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals

NCT ID: NCT03741621

Last Updated: 2018-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

1992-01-31

Study Completion Date

2010-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the role of fibre viscosity (low, medium, high) in lowering cholesterol in healthy individuals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipidemia Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Viscosity

viscous fibre blend added to breakfast cereals consumed in the context of a typical North American diet for 3 weeks duration

Group Type EXPERIMENTAL

Viscous Fibre Blend

Intervention Type DIETARY_SUPPLEMENT

High viscosity viscous fiber blend sprinkled on wheat and maize bran cereals(Bran Buds®; Kellogg Company)

Medium Viscosity

Kellogg's Bran buds with psyllium breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration

Group Type EXPERIMENTAL

Psyllium

Intervention Type DIETARY_SUPPLEMENT

Bran Buds cereal (white bran and maize bran) with psyllium (Bran Buds® with PSY; Kellogg Company)

Low Viscosity

Kellogg's All Bran breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration

Group Type EXPERIMENTAL

Wheat Bran

Intervention Type DIETARY_SUPPLEMENT

All Bran cereal (All Bran®; Kellogg Company)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Viscous Fibre Blend

High viscosity viscous fiber blend sprinkled on wheat and maize bran cereals(Bran Buds®; Kellogg Company)

Intervention Type DIETARY_SUPPLEMENT

Psyllium

Bran Buds cereal (white bran and maize bran) with psyllium (Bran Buds® with PSY; Kellogg Company)

Intervention Type DIETARY_SUPPLEMENT

Wheat Bran

All Bran cereal (All Bran®; Kellogg Company)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-healthy individuals

Exclusion Criteria

* regular alcohol consumption
* regular smoking
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kellogg Company

INDUSTRY

Sponsor Role collaborator

University of Toronto

OTHER

Sponsor Role collaborator

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

viscosity and cholesterol

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.